Welcome to MolDiag-PaCa

in cooperation with the DiMI / EMIL Summer School 2008 �Cardiovascular Applications of Molecular Imaging�

The Molecular Imaging Workshop within the MolDiag-Paca network took place at the University Hospital Muenster, Monday 1st September 2008.
The course was attended by 21 clinicians/scientists interested in molecular imaging techniques/modalities. The contents spanned everything from clinically relevant imaging approaches (e.g. MRI, CT, PET) to pre-clinical/basic research imaging platforms like fluorescence mediated tomography (FMT) or fluorescence reflectance imaging (FRI). Another topic focused on probe design and molecular imaging applications for in vivo drug screening, which offered an deeper insight of the multidisciplinary interaction in this new and rapidly growing research discipline.

The course covered the following program:

  • FRI/FMT � principles of operation and molecular imaging � Jens Waldeck, Münster
    (in parallel at the Summer School: Basic Physiology of the Cardiovascular System, Ulrich Decking, Düsseldorf)
  • PET � principles of operation and molecular imaging � Lars Stegger, Münster
  • Ultrasound/echo � principles of operation and molecular imaging � Georg Schmitz, Bochum
  • CT � principles of operation � Stefan Käpplinger, Erlangen
  • MRI � principles of operation and molecular imaging � Cornelius Faber, Würzburg/Münster
  • Molecular imaging for in vivo drug screening � Normann Koglin, Berlin
    (in parallel at the Summer School: Co-registration of moving structures (heart, vessels ...), Klaus Schäfers, Münster)
  • The chemistry behind tracers � Carsten Höltke, Münster
  • Pitfalls in Tracer development and imaging � Christoph Bremer, Münster
    (in parallel at the Summer School: Meet the experts � open discussion, all speaker)
  • Lab-Tour (FRI/FMT/3T MRT) � Bremer/Waldeck, Münster

! Proposal for partner to join our Integrated Project !

Our consortium, active in the Sixth Framework Programme of the European Community for research, technological development and demonstration activities contributing to the creation of the European Research Area and to innovation (2002-2006), requires the participation of a new project partner to carry out certain tasks within the project.

The new partner will act as a full-member of the consortium. Its main activity will be related to WP1 goals. Because the focus of the new member will be to support WP1 goals, it is mandatory that experience in the application of epidemiological methods is demonstrated.

Full call text
Guide for proposers
Consortium Agreement
Annex II

Electronic submission is not possible for this call - only paper submission is allowed:
As the Commission`s Electronic Proposal Submission System (EPSS) is adapted to the 7th Framework Programme (FP7) you cannot use the EPSS for this FP6 call.
The Guide for Proposers states under 3.2 to complete the forms electronically, however this is not possible in this case.

For help please contact the MolDiag-Paca project office:
Dr Björg Pauling or Esther Buchholz
Tel.: ++49 (0)6421 2866853
FAX: ++49 (0)6421 2866855
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it.



  • MolDiag-Paca Consortium: "A Pancreas Cancer Research Celebration" CNIO Madrid,
    June 8th 2009, 16-19:30
    We desperately need to make progress towards reducing pancreas cancer mortality. Recent advances in mouse models of the disease, the genetic factors involved in its development, and in the treatment of patients with respectable tumours are paving the way to making such progress
        
  • WORKSHOP: Epidemiology and its application to pancreatic cancer.
    On Feb 5 a MolDiagPaca workshop on epidemiology and its application to pancreatic cancer will be held at CNIO in Madrid, Spain. Renowned speakers will present on basic principles of epidemiology, and give an overview of genetic epidemiology, environmental and genetic factors of pancreatic cancer, including possible susceptibility genes in sporadic disease vs. familial disease. The magnitude of the disease will be presented and etiological factors and somatic genetic alterations in pancreas cancer will be addressed. Finally, future directions in pancreatic cancer research will be outlined.
        
  • Executive Summary of our second annual report with MolDiagPaca accomplishments during its second year
         
  • MolDiag-Paca Workshop "Molecular Imaging"
    University Hospital Muenster, 1st September 2008
       
  • The Teaching course on the pathology of pancreatic tumors is now in the internet! Please click here to access the e-learning course.
     
  • Executive Summary of our first annual report with MolDiagPaca accomplishments during its first year
     
  • The Clinical course on pancreatic cancer within the MolDiagPaCa network took place at the Karolinska University Hospital in Stockholm, Sweden on November 23, 2007. The course was especially adapted to the needs of non-clinical pancreatic cancer researchers and as a refreshment course for clinicians.
     
  • The Teaching course on the pathology of pancreatic tumors took place in Verona, on May 18th 2007 with 88 participants, 34 of which were not directly involved with MolDiagPaca: In the last few years, new concepts regarding the histological and molecular subclassification of exocrine pancreatic tumors have been established.
     
  • The MolTools - DKFZ - IGB - MolDiagPaca Practical Course: Analysis and Interpretation of Complex Transcript Data took place at DKFZ in Heidelberg during the period Thursday, 14 December, to Saturday, 16 December 2006. In total 16 scientists of different European countries participated.

The Clinical course on pancreatic cancer within the MolDiagPaCa network took place at the Karolinska University Hospital in Stockholm, Sweden on November 23, 2007.

The course was especially adapted to the needs of non-clinical pancreatic cancer researchers and as a refreshment course for clinicians. The contents spanned everything from clinically relevant embryology and anatomy, through diagnostics using imaging, cytology, histology and molecular tools, to current medical and surgical treatment strategies. The general theme of the course highlighted multidisciplinarity in diagnostics, decision making and treatment, and course participants took during the one day course part in the weekly multidisciplinary pancreatic cancer video conference between the hospitals in the Stockholm area.

The course covered the following program:

Clinical presentation and symptoms of pancreatic cancer.
Ake Andren-Sandberg

Anatomy and embryology of the pancreas
Ake Andren-Sandberg

Approaches to drainage of the biliary tract in pancreatic cancer
Urban Arnelo

Diagnostic imaging of pancreatic cancer
Nick Edsborg

Live Pancreatic Tumour Conference
Johan Permert and Ake Andren-Sandberg

Surgical management of pancreatic cancer
John Neoptolemos

The role of chemotherapy and radiotherapy in adjuvant, palliative . and locally advanced settings in pancreatic cancer
Pehr Lind

Summarizing case discussion
Johan Permert and Ake Andren-Sandberg